{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:15:56Z","timestamp":1762866956842,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.eimce.2022.07.009","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T18:09:20Z","timestamp":1674670160000},"page":"596-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia"],"prefix":"10.1016","volume":"41","author":[{"given":"Let\u00edcia","family":"Kraft","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria Stadler Tasca","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geiziane Aparecida","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Hansen","family":"Suss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Francisco","family":"Tuon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2022.07.009_bib0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10096-002-0697-1","article-title":"Risk factors for breakthrough candidemia","volume":"21","author":"Nucci","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimce.2022.07.009_bib0235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2217\/fmb-2016-0223","article-title":"Breakthrough candidemia in children: clinical and microbiological characteristics, therapeutic strategies and impact on outcomes","volume":"12","author":"Lai","year":"2017","journal-title":"Future Microbiol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0240","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/mmy\/myx077","article-title":"Breakthrough candidemia after the introduction of broad spectrum antifungal agents: a 5-year retrospective study","volume":"56","author":"Breda","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cmi.2015.09.029","article-title":"Breakthrough candidaemia in the era of broad-spectrum antifungal therapies","volume":"22","author":"Cuervo","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimce.2022.07.009_bib0250","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijantimicag.2014.05.015","article-title":"Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpoints","volume":"44","author":"Gamaletsou","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimce.2022.07.009_bib0255","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/pathogens6040062","article-title":"Liposomal and deoxycholate Amphotericin B formulations: effectiveness against biofilm infections of Candida spp","volume":"6","author":"Rodrigues","year":"2017","journal-title":"Pathogens"},{"key":"10.1016\/j.eimce.2022.07.009_bib0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro821","article-title":"Bacterial biofilms: from the natural environment to infectious diseases","volume":"2","author":"Hall-Stoodley","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0265","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2022.07.009_bib0270","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin study G: anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2022.07.009_bib0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.riam.2012.09.003","article-title":"Are there risk factors for acute renal failure in adult patients using deoxycholate amphotericin B?","volume":"30","author":"Tuon","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.riam.2017.03.003","article-title":"Long-term cost-effectiveness of lipid formulations of amphotericin B in the empirical therapy of invasive mycosis in a developing country","volume":"34","author":"Tuon","year":"2017","journal-title":"Rev Iberoam Micol"},{"issue":"Suppl. 6","key":"10.1016\/j.eimce.2022.07.009_bib0285","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1086\/429335","article-title":"Study of renal safety in amphotericin B lipid complex-treated patients","volume":"40","author":"Alexander","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2022.07.009_bib0290","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/320757","article-title":"Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia","volume":"32","author":"Uzun","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2022.07.009_bib0295","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41409-019-0541-1","article-title":"Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Kaito","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.eimce.2022.07.009_bib0300","doi-asserted-by":"crossref","first-page":"e01791","DOI":"10.1128\/AAC.01791-16","article-title":"Clinical and microbiological characteristics of breakthrough candidemia in allogeneic hematopoietic stem cell transplant recipients in a Japanese hospital","volume":"61","author":"Kimura","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2022.07.009_bib0305","unstructured":"CLSI: Reference method for broth dilution antifungal susceptibility testing of yeasts; Fourth international supplement. CLSI document M27-S4 (ISBN 1-56238-863-0). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 U.S.A. 2012."},{"key":"10.1016\/j.eimce.2022.07.009_bib0310","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/jcm.22.6.996-1006.1985","article-title":"Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices","volume":"22","author":"Christensen","year":"1985","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0315","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mimet.2007.11.010","article-title":"Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates","volume":"72","author":"Peeters","year":"2008","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.eimce.2022.07.009_bib0320","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/08927014.2011.602188","article-title":"Susceptibility of Staphylococcus aureus biofilms to reactive discharge gases","volume":"27","author":"Traba","year":"2011","journal-title":"Biofouling"},{"key":"10.1016\/j.eimce.2022.07.009_bib0325","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/mmy\/myx038","article-title":"Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents","volume":"56","author":"Kim","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0330","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/IAI.72.10.6023-6031.2004","article-title":"Development and characterization of an in vivo central venous catheter Candida albicans biofilm model","volume":"72","author":"Andes","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.eimce.2022.07.009_bib0335","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019729","article-title":"Fungal biofilms, drug resistance, and recurrent infection","volume":"4","author":"Desai","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.eimce.2022.07.009_bib0340","doi-asserted-by":"crossref","first-page":"e15933","DOI":"10.1097\/MD.0000000000015933","article-title":"Invasive candidiasis: risk factor for mortality in a pediatric tertiary care hospital in south of Brazil","volume":"98","author":"Rodrigues","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimce.2022.07.009_bib0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11046-020-00509-x","article-title":"Virulence factors and antifungal susceptibility in Candida species isolated from dermatomycosis patients","volume":"186","author":"Mello","year":"2021","journal-title":"Mycopathologia"},{"key":"10.1016\/j.eimce.2022.07.009_bib0350","doi-asserted-by":"crossref","first-page":"104889","DOI":"10.1016\/j.micpath.2021.104889","article-title":"The relationship between biofilm formation and mortality in patients with Candida tropicalis candidemia","volume":"155","author":"Sasani","year":"2021","journal-title":"Microb Pathog"},{"key":"10.1016\/j.eimce.2022.07.009_bib0355","first-page":"8","article-title":"The evaluation of the virulence factors of clinical Candida isolates and the anti-biofilm activity of Elettaria cardamomum against multi-drug resistant Candida albicans","volume":"2","author":"Vijayalakshmi","year":"2016","journal-title":"Curr Med Mycol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0360","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/13693786.2010.530032","article-title":"Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex","volume":"49","author":"Melo","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0365","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.01141-06","article-title":"Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals","volume":"51","author":"Choi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2022.07.009_bib0370","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2022.07.009_bib0375","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.02288-12","article-title":"Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model","volume":"57","author":"Kucharikova","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2022.07.009_bib0380","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ja.2013.83","article-title":"In vitro effectiveness of anidulafungin against Candida spp. biofilms","volume":"66","author":"Rosato","year":"2013","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.eimce.2022.07.009_bib0385","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1128\/AAC.00676-07","article-title":"Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species","volume":"51","author":"Melo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimce.2022.07.009_bib0390","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2174\/138945006776359458","article-title":"Biofilms and their role in the resistance of pathogenic Candida to antifungal agents","volume":"7","author":"d\u2019Enfert","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.eimce.2022.07.009_bib0395","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.cmi.2016.09.016","article-title":"Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia","volume":"23","author":"Rueda","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimce.2022.07.009_bib0400","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s11274-013-1326-0","article-title":"Use of MTT assay for determination of the biofilm formation capacity of microorganisms in metalworking fluids","volume":"29","author":"Trafny","year":"2013","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0405","doi-asserted-by":"crossref","first-page":"e38492","DOI":"10.1371\/journal.pone.0038492","article-title":"Inhibition of biofilm formation, quorum sensing and infection in Pseudomonas aeruginosa by natural products-inspired organosulfur compounds","volume":"7","author":"Cady","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.eimce.2022.07.009_bib0410","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MB-0020-2015","article-title":"Candida biofilms: development, architecture, and resistance","volume":"3","author":"Chandra","year":"2015","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.eimce.2022.07.009_bib0415","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/pathogens7010006","article-title":"What could be the role of antifungal lock-solutions? From bench to bedside","volume":"7","author":"Imbert","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.eimce.2022.07.009_bib0420","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s10156-011-0224-3","article-title":"In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species","volume":"17","author":"\u00d6ncu","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.eimce.2022.07.009_bib0425","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/00006454-199410000-00015","article-title":"Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients","volume":"13","author":"Johnson","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimce.2022.07.009_bib0430","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/clinids\/21.5.1286","article-title":"Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home","volume":"21","author":"Benoit","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2022.07.009_bib0435","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1086\/323554","article-title":"Should lock therapy always be avoided for central venous catheter\u2013associated fungal bloodstream infections?","volume":"33","author":"Viale","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2022.07.009_bib0440","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fmicb.2017.00036","article-title":"Antifungal therapy: new advances in the understanding and treatment of mycosis","volume":"8","author":"Scorzoni","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.eimce.2022.07.009_bib0445","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mimet.2010.08.018","article-title":"In vitro and in vivo model systems to study microbial biofilm formation","volume":"83","author":"Coenye","year":"2010","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.eimce.2022.07.009_bib0450","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","article-title":"Candida albicans biofilms and human disease","volume":"69","author":"Nobile","year":"2015","journal-title":"Ann Rev Microbiol"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X23000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X23000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:02:31Z","timestamp":1762866151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X23000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2529993X23000205"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2022.07.009","relation":{},"ISSN":["2529-993X"],"issn-type":[{"type":"print","value":"2529-993X"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2022.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica.","name":"copyright","label":"Copyright"}]}}